DiDi Global Total Long-Term Assets 2021-2021 | DIDIY
DiDi Global total long-term assets from 2021 to 2021. Total long-term assets can be defined as the sum of all assets classified as non-current
- DiDi Global total long-term assets for the quarter ending September 30, 2021 were $12.229B, a INF% increase year-over-year.
- DiDi Global total long-term assets for 2023 were $11.036B, a 5.05% decline from 2022.
- DiDi Global total long-term assets for 2022 were $11.622B, a 12.07% decline from 2021.
- DiDi Global total long-term assets for 2021 were $13.218B, a 10.2% increase from 2020.
| DiDi Global Annual Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2023 | $11,036 |
| 2022 | $11,622 |
| 2021 | $13,218 |
| 2020 | $11,994 |
| DiDi Global Quarterly Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2021-09-30 | $12,229 |
| 2021-03-31 | $14,424 |
| 2020-12-31 | $12,765 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $23.427B | $27.096B |
| DiDi Global Inc. provides mobility technology platform. It offers app-based services across Asia Pacific, Latin America and Africa as well as in Central Asia and Russia, including ride hailing, taxi hailing, chauffeur, hitch and other forms of shared mobility as well as auto solutions, food delivery, intra-city freight and financial services. DiDi Global Inc. is based in BEIJING. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $98.658B | 12.24 |
| Cencora (COR) | United States | $49.082B | 18.10 |
| ICON (ICLR) | Ireland | $17.504B | 15.59 |
| Natera (NTRA) | United States | $16.570B | 0.00 |
| Viatris (VTRS) | United States | $15.624B | 4.81 |
| Avantor (AVTR) | United States | $15.178B | 22.75 |
| Revvity (RVTY) | United States | $14.682B | 25.50 |
| BioMerieux (BMXMF) | France | $13.087B | 0.00 |
| CochLear (CHEOY) | Australia | $12.998B | 0.00 |
| Solventum (SOLV) | United States | $12.357B | 0.00 |
| Doximity (DOCS) | United States | $11.372B | 67.31 |
| Medpace Holdings (MEDP) | United States | $11.301B | 31.84 |
| Charles River Laboratories (CRL) | United States | $11.285B | 21.81 |
| HealthEquity (HQY) | United States | $8.756B | 47.52 |
| Sonic Healthcare (SKHHY) | Australia | $8.590B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $7.202B | 33.53 |
| Life Times (LTH) | United States | $5.139B | 34.01 |
| Sotera Health (SHC) | United States | $4.509B | 24.12 |
| Organon (OGN) | United States | $4.144B | 4.18 |
| Surgery Partners (SGRY) | United States | $3.996B | 44.27 |
| BrightSpring Health Services (BTSG) | United States | $3.489B | 74.22 |
| PACS (PACS) | United States | $3.347B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.580B | 0.00 |
| Concentras Parent (CON) | United States | $2.505B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.471B | 0.00 |
| Premier (PINC) | United States | $2.314B | 11.55 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.016B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.856B | 48.90 |
| Teladoc Health (TDOC) | United States | $1.689B | 0.00 |
| Progyny (PGNY) | United States | $1.540B | 27.08 |
| Pediatrix Medical (MD) | United States | $1.371B | 13.41 |
| Establishment Labs Holdings (ESTA) | $1.266B | 0.00 | |
| CareDx (CDNA) | United States | $1.252B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.058B | 7.16 |
| Embecta (EMBC) | United States | $0.910B | 6.07 |
| Agilon Health (AGL) | United States | $0.890B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.809B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| SBC Medicals (SBC) | United States | $0.723B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.516B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.459B | 0.00 |
| DocGo (DCGO) | United States | $0.411B | 15.46 |
| Enhabit (EHAB) | United States | $0.403B | 34.83 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.363B | 0.00 |
| LifeMD (LFMD) | United States | $0.308B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.248B | 0.00 |
| ModivCare (MODV) | United States | $0.231B | 12.54 |
| Beauty Health (SKIN) | United States | $0.218B | 0.00 |
| Biodesix (BDSX) | United States | $0.205B | 0.00 |
| Nutex Health (NUTX) | United States | $0.152B | 0.00 |
| MultiPlan (MPLN) | United States | $0.137B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.107B | 0.00 |
| So-Young (SY) | China | $0.088B | 21.28 |
| Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.054B | 0.00 |
| OncoCyte (OCX) | United States | $0.049B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.10 |
| Co-Diagnostics (CODX) | United States | $0.038B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.028B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| Oncology Institute (TOI) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |